The JAK–STAT pathway: an emerging target for cardiovascular disease in rheumatoid arthritis and myeloproliferative neoplasms

C Baldini, FR Moriconi, S Galimberti… - European Heart …, 2021 - academic.oup.com
Inflammation contributes centrally to cardiovascular diseases, and anti-inflammatory
treatments can reduce cardiovascular events. The JAK–STAT pathway is an emerging target …

[HTML][HTML] Health position paper and redox perspectives-Disease burden by transportation noise

M Sørensen, G Pershagen, JD Thacher, T Lanki… - Redox Biology, 2023 - Elsevier
Transportation noise is a ubiquitous urban exposure. In 2018, the World Health Organization
concluded that chronic exposure to road traffic noise is a risk factor for ischemic heart …

Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis, and cardiac dysfunction

JC Zhong, R Basu, D Guo, FL Chow, S Byrns… - Circulation, 2010 - Am Heart Assoc
Background—Angiotensin-converting enzyme 2 (ACE2) is a pleiotropic
monocarboxypeptidase capable of metabolizing several peptide substrates. We …

Pleiotropic AT1 Receptor Signaling Pathways Mediating Physiological and Pathogenic Actions of Angiotensin II

L Hunyady, KJ Catt - Molecular endocrinology, 2006 - academic.oup.com
Abstract Angiotensin II (Ang II) activates a wide spectrum of signaling responses via the AT1
receptor (AT1R) that mediate its physiological control of blood pressure, thirst, and sodium …

The myocardial JAK/STAT pathway: from protection to failure

K Boengler, D Hilfiker-Kleiner, H Drexler… - Pharmacology & …, 2008 - Elsevier
Proteins of the interleukin-6 (IL-6) family bind to receptors in the plasma membrane.
Subsequent signal transduction involves activation of the janus kinase (JAK) and signal …

Survival pathways in hypertrophy and heart failure: the gp130-STAT3 axis

P Fischer, D Hilfiker-Kleiner - Basic research in cardiology, 2007 - Springer
Circulating levels of interleukin (IL)–6 and related cytokines are elevated in patients with
congestive heart failure and after myocardial infarction. Serum IL-6 concentrations are …

Mitochondrial-targeted Signal transducer and activator of transcription 3 (STAT3) protects against ischemia-induced changes in the electron transport chain and the …

K Szczepanek, Q Chen, M Derecka, FN Salloum… - Journal of Biological …, 2011 - ASBMB
Expression of the STAT3 transcription factor in the heart is cardioprotective and decreases
the levels of reactive oxygen species. Recent studies indicate that a pool of STAT3 resides …

A century old renin–angiotensin system still grows with endless possibilities: AT1 receptor signaling cascades in cardiovascular physiopathology

P Balakumar, G Jagadeesh - Cellular signalling, 2014 - Elsevier
Ang II, the primary effector pleiotropic hormone of the renin–angiotensin system (RAS)
cascade, mediates physiological control of blood pressure and electrolyte balance through …

The JAK/STAT pathway is essential for opioid-induced cardioprotection: JAK2 as a mediator of STAT3, Akt, and GSK-3β

ER Gross, AK Hsu, GJ Gross - American Journal of …, 2006 - journals.physiology.org
We examined the role for the JAK/STAT signaling pathway in acute opioid-induced
cardioprotection (OIC) and whether opioid-induced glycogen synthase kinase-3β (GSK-3β) …

Cardioprotective effect of ghrelin against myocardial infarction-induced left ventricular injury via inhibition of SOCS3 and activation of JAK2/STAT3 signaling

RA Eid, MA Alkhateeb, S Eleawa… - Basic research in …, 2018 - Springer
The molecular mechanisms through which ghrelin exerts its cardioprotective effects during
cardiac remodeling post-myocardial infarction (MI) are poorly understood. The aim of this …